inforevision statsautoriseret revisionsaktieselskab

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.2% 1.2% 1.2% 1.2% 1.2%  
Bankruptcy risk  2.1% 1.4% 1.1% 1.1% 0.9%  
Credit score (0-100)  66 76 84 83 88  
Credit rating  BBB A A A A  
Credit limit (mDKK)  0.0 0.3 2.8 2.6 4.1  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (mDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  126 148 150 153 157  
Gross profit  107 131 131 127 130  
EBITDA  13.2 21.7 22.5 25.2 24.0  
EBIT  10.8 17.6 20.8 23.6 22.2  
Pre-tax profit (PTP)  10.6 18.7 21.7 24.7 23.6  
Net earnings  8.3 14.7 17.0 19.3 18.5  
Pre-tax profit without non-rec. items  10.6 18.7 21.7 24.7 23.6  

 
See the entire income statement

Balance sheet (mDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  8.2 6.5 5.3 4.8 7.6  
Shareholders equity total  9.5 15.7 18.2 20.5 19.9  
Interest-bearing liabilities  3.2 4.9 3.7 4.3 3.5  
Balance sheet total (assets)  61.8 74.7 74.6 79.0 69.8  

Net Debt  2.2 4.9 -19.8 -22.2 -6.7  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  126 148 150 153 157  
Net sales growth  2.3% 16.8% 1.7% 2.2% 2.3%  
Gross profit  107 131 131 127 130  
Gross profit growth  2.5% 22.9% 0.2% -3.4% 2.2%  
Employees  126 123 121 122 126  
Employee growth %  -2.3% -2.4% -1.6% 0.8% 3.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  62 75 75 79 70  
Balance sheet change%  14.2% 20.8% -0.1% 5.9% -11.6%  
Added value  13.2 21.7 22.5 25.4 24.0  
Added value %  10.4% 14.7% 15.0% 16.5% 15.3%  
Investments  -0 -8 -3 -2 1  

Net sales trend  4.0 5.0 5.0 5.0 5.0  
EBIT trend  5.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  10.4% 14.7% 15.0% 16.4% 15.3%  
EBIT %  8.6% 11.9% 13.8% 15.4% 14.1%  
EBIT to gross profit (%)  10.2% 13.4% 15.8% 18.6% 17.1%  
Net Earnings %  6.5% 10.0% 11.3% 12.6% 11.8%  
Profit before depreciation and extraordinary items %  8.4% 12.8% 12.5% 13.6% 12.9%  
Pre tax profit less extraordinaries %  8.4% 12.7% 14.4% 16.1% 15.0%  
ROA %  20.3% 27.9% 29.3% 32.3% 31.9%  
ROI %  53.6% 68.4% 66.5% 73.1% 70.9%  
ROE %  84.0% 117.0% 100.1% 99.8% 91.5%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  15.3% 21.1% 24.4% 25.9% 28.5%  
Relative indebtedness %  38.7% 38.0% 35.1% 36.1% 29.5%  
Relative net indebtedness %  38.0% 37.9% 19.4% 18.8% 22.9%  
Net int. bear. debt to EBITDA, %  17.0% 22.5% -88.0% -88.1% -28.1%  
Gearing %  33.4% 31.2% 20.6% 21.0% 17.7%  
Net interest  0 0 0 0 0  
Financing costs %  32.1% 6.8% 3.6% 2.4% 2.7%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.1 1.3 1.4 1.4 1.4  
Current Ratio  1.1 1.3 1.4 1.4 1.4  
Cash and cash equivalent  0.9 0.0 23.5 26.5 10.3  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  48.0 54.0 44.0 48.5 55.0  
Trade creditors turnover (days)  89.9 120.5 102.1 82.9 50.4  
Current assets / Net sales %  36.0% 42.0% 42.3% 44.9% 36.2%  
Net working capital  4.5 14.0 19.1 19.4 16.5  
Net working capital %  3.6% 9.5% 12.8% 12.7% 10.5%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  1 1 1 1 1  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0